Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005987
Status:
TERMINATED
Last Update Posted:
2017-11-29
First Post:
2000-07-05
Brief Title:
Filgrastim Compared With Sargramostim Plus Chemotherapy Peripheral Stem Cell Transplantation and Interferon Alfa in Treating Patients With Multiple Myeloma
Sponsor:
Masonic Cancer Center University of Minnesota
Organization:
Masonic Cancer Center University of Minnesota
Organization Data
Organization:
Masonic Cancer Center University of Minnesota
Class:
OTHER
Study ID:
1996LS137
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Masonic Cancer Center University of Minnesota
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None